Showing results (61-70 of 254) with videos related to
Sort By:
Pageof 26
Clinics in Dermatology|December 18, 2003
Changing paradigms in dermatology: nuclear hormone receptorsLaura Winterfield, Jennifer Cather, John Cather, et al.Journal of the American Academy of Dermatology|January 25, 2002
Cardiocutaneous syndromes and associationsNagla F Abdelmalek, Terry L Gerber, Alan MenterExpert Opinion on Biological Therapy|March 29, 2003
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumabJennifer Clay Cather, J Christian Cather, Alan MenterProceedings (Baylor University. Medical Center)|April 7, 2012
Widespread dermal ulcerations and bullaeJay Wofford, Mahir Patel, Allison Readinger, et al.Dermatology and Therapy|December 31, 2015
A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque PsoriasisMolly Campa, Bobbak Mansouri, Richard Warren, et al.Dermatology and Therapy|January 18, 2020
The Validity of Cutaneous Body Image as a Construct and as a Mediator of the Relationship Between Cutaneous Disease and Mental HealthSarah B Hinkley, Shayla C Holub, Alan MenterJournal of the American Academy of Dermatology|February 28, 2004
Combination therapy to treat moderate to severe psoriasisMark Lebwohl, Alan Menter, John Koo, et al.Proceedings (Baylor University. Medical Center)|April 6, 2019
Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinibIsabel M Haugh, Ian T Watson, M Alan MenterJournal of Drugs in Dermatology : JDD|June 12, 2014
A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009Elizabeth Farley Prater, Antoinette Day, Mahir Patel, et al.Expert Opinion on Biological Therapy|March 12, 2010
The use of ustekinumab in autoimmune diseaseCaitriona Ryan, Breck Thrash, Richard B Warren, et al.Pageof 26